Herantis Pharma Plc.   Report issue

For profit Phase 1 Phase 2
Founded: Helsinki Finland (2008)

Organization Overview

First Clinical Trial
2014
NCT02326090
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Herantis Pharma Plc.